Genrobotics posts ₹2.6 Cr profit, eyes ₹150 Cr Series B

Key Takeaways

• Genrobotics FY26 revenue grew 35% to ₹43.7 Cr while PAT nearly tripled to ₹2.6 Cr
• The startup is raising ₹150 Cr Series B with 80-90% earmarked for manufacturing expansion
• Company targets 5X revenue growth to ₹219.9 Cr in FY27 across sanitation, medical robotics, defence, and space verticals

Genrobotics, the Thiruvananthapuram-based robotics company backed by Zoho and Peak XV Partners, posted a profit of ₹2.6 Cr in FY26, nearly tripling from ₹90 Lakh a year earlier. Operating revenue climbed 35% to ₹43.7 Cr. The startup is now in talks for a ₹150 Cr Series B round, with most of the capital headed toward manufacturing expansion.

Founded in 2017 by Vimal Govind MK, Arun George, Nikhil NP, and Rashid K, Genrobotics builds machines for work too dangerous or difficult for humans. Its flagship product, Bandicoot, automates manhole and sewer cleaning. The technology directly targets manual scavenging, a practice that, despite being banned in India, still kills workers every year from toxic gas exposure.

How did Genrobotics improve margins in FY26?

The numbers tell a clear story of operating leverage kicking in. EBITDA rose 74% to ₹6.6 Cr, with margins expanding from 11.6% to 15.2%. PAT margin more than doubled, from 2.8% to 6%. For a hardware robotics company, that margin expansion signals better unit economics as production scales.

CEO Vimal Govind MK attributes the improvement to stronger product-market fit across verticals and competitive pricing. The company has also deepened its manufacturing capabilities. It currently operates about 30,000 sq ft of production space across Kerala and Andhra Pradesh, including a 5,000 sq ft medical robotics unit at the Andhra Pradesh MedTech Zone.

Why does Genrobotics need ₹150 Cr now?

The startup projects 5X revenue growth in FY27, targeting ₹219.9 Cr. That kind of jump requires serious manufacturing capacity. Govind says 80-90% of the Series B will go toward production expansion.

“My focus is on expanding our production centres because we need more manufacturing capacity. This year, we have a ₹155 Cr revenue pipeline, of which nearly ₹100 Cr is already booked through tenders, purchase orders and other contracts.”

— Vimal Govind MK, Co-founder & CEO, Genrobotics

The company plans new facilities in Uttar Pradesh and Hyderabad. A new Kerala unit is expected to double manufacturing footprint to 60,000 sq ft. Over five years, Genrobotics aims to scale to 5 lakh sq ft and ₹1,600 Cr in annual revenue.

Genrobotics has raised over ₹100 Cr to date, including debt. Its investor roster includes Zoho, Unicorn India Ventures, Peak XV Partners, and Anand Mahindra. The company is in talks with both domestic and international investors for the Series B, though Govind declined to name them.

What does Genrobotics actually build?

The company operates across four verticals: sanitation, medical robotics, defence, and space technology. Sanitation currently generates about 60% of revenue, with medical robotics contributing 40%. Defence and space remain early-stage.

In medical robotics, Genrobotics develops rehabilitation systems for stroke patients, spinal cord injuries, and Parkinson's disease. Its G-Gait robotic exoskeleton guides patients through repeated walking movements. Upper-body systems help restore movements needed for daily activities.

On the defence side, the company is developing autonomous rovers for reconnaissance and hazard neutralization in hostile terrain. In space tech, it is building robotic arms for debris removal and satellite servicing, including inspection, repair, and refueling.

The startup has filed more than 30 patents and holds over 20 intellectual properties, with 10 granted in India and overseas markets.

Why is government adoption critical?

Sanitation robotics sells primarily to municipal governments. That means long sales cycles, pilots, and validation before scale contracts arrive. Govind acknowledges this reality but sees the payoff once trust is established.

“Sanitation is going to drive the majority of our revenue. It has taken time because government adoption requires pilots and validation, but once trust is established, the scale comes rapidly.”

— Vimal Govind MK, Co-founder & CEO, Genrobotics

The ₹100 Cr already booked through tenders and purchase orders suggests that trust is building. For a hardware startup selling to government, converting pipeline to contracts is the hard part. Genrobotics appears to have crossed that threshold in sanitation.

What's next for Genrobotics?

The company is developing G-Bot, a bipedal robot, and GenBot, a semi-humanoid system. It targets an indigenous bipedal-walking demonstration by the end of FY27. These products sit outside its current revenue-generating verticals but signal ambitions beyond industrial and medical applications.

Still, Govind says the startup will remain focused on its four existing verticals. The expansion into humanoid robotics appears to be R&D positioning rather than a near-term revenue play.

Frequently Asked Questions

How much funding has Genrobotics raised to date?

Genrobotics has raised over ₹100 Cr to date, including debt. Investors include Zoho, Unicorn India Ventures, Peak XV Partners, and Anand Mahindra.

What is Bandicoot robot used for?

Bandicoot automates manhole and sewer cleaning, eliminating the need for workers to enter confined, toxic spaces. It is designed to replace manual scavenging in India.

What is Genrobotics' revenue target for FY27?

Genrobotics targets ₹219.9 Cr in revenue for FY27, representing over 5X growth from FY26's ₹43.7 Cr.

Which verticals does Genrobotics operate in?

Genrobotics operates in sanitation, medical robotics, defence, and space technology. Sanitation accounts for 60% of current revenue, medical robotics for 40%.

Where are Genrobotics' manufacturing facilities located?

The company has production facilities in Kerala and Andhra Pradesh, totaling about 30,000 sq ft. It plans new units in Uttar Pradesh, Hyderabad, and Kerala.

Source: Inc42 Media / Shrishti Bisht